43 related articles for article (PubMed ID: 3236215)
1. Which is the best option?: An updated review of the most widely used technical variations in entero-enteric anastomosis to minimise delayed gastric emptying after partial pancreatoduodenectomy.
Martín S; Busquets J; Fabregat J
Cir Esp (Engl Ed); 2023 Dec; 101(12):847-850. PubMed ID: 36265772
[No Abstract] [Full Text] [Related]
2. Influence of food on aspirin absorption from tablets and buffered solutions.
Mason WD; Winer N
J Pharm Sci; 1983 Jul; 72(7):819-21. PubMed ID: 6886992
[TBL] [Abstract][Full Text] [Related]
3. Drugs, diseases and altered gastric emptying.
Nimmo WS
Clin Pharmacokinet; 1976; 1(3):189-203. PubMed ID: 797497
[TBL] [Abstract][Full Text] [Related]
4. Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole.
Bae S; Kwon J; Lee SB; Jang IJ; Yu KS; Lee S
Drug Des Devel Ther; 2021; 15():5099-5108. PubMed ID: 34992346
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation.
Angiolillo DJ; Bhatt DL; Lanza F; Deliargyris EN; Prats J; Fan W; Marathi U
J Thromb Thrombolysis; 2020 Apr; 49(3):337-343. PubMed ID: 32080811
[TBL] [Abstract][Full Text] [Related]
6. Low dose lipid formulations: effects on gastric emptying and biliary secretion.
Kossena GA; Charman WN; Wilson CG; O'Mahony B; Lindsay B; Hempenstall JM; Davison CL; Crowley PJ; Porter CJ
Pharm Res; 2007 Nov; 24(11):2084-96. PubMed ID: 17657595
[TBL] [Abstract][Full Text] [Related]
7. Floating granules of ranitidine hydrochloride-gelucire 43/01: formulation optimization using factorial design.
Patel DM; Patel NM; Patel VF; Bhatt DA
AAPS PharmSciTech; 2007 Apr; 8(2):Article 30. PubMed ID: 17622108
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of diltiazem hydrochloride-Gelucire 43/01 floating granules prepared by melt granulation.
Shimpi S; Chauhan B; Mahadik KR; Paradkar A
AAPS PharmSciTech; 2004 Jul; 5(3):e43. PubMed ID: 15760076
[TBL] [Abstract][Full Text] [Related]
9. Novel oral drug formulations. Their potential in modulating adverse effects.
Florence AT; Jani PU
Drug Saf; 1994 Mar; 10(3):233-66. PubMed ID: 8043223
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic considerations in gastrointestinal motor disorders.
Hebbard GS; Sun WM; Bochner F; Horowitz M
Clin Pharmacokinet; 1995 Jan; 28(1):41-66. PubMed ID: 7712661
[TBL] [Abstract][Full Text] [Related]
11. Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications.
Gubbins PO; Bertch KE
Clin Pharmacokinet; 1991 Dec; 21(6):431-47. PubMed ID: 1782738
[TBL] [Abstract][Full Text] [Related]
12. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
13. Gastric emptying and absorption of acetylsalicylic acid administered as enteric-coated micro-granules.
Alpsten M; Bogentoft C; Ekenved G; Sölvell L
Eur J Clin Pharmacol; 1982; 22(1):57-61. PubMed ID: 7094976
[TBL] [Abstract][Full Text] [Related]
14. Enteric coated naproxen tablets.
Gamst ON
Eur J Rheumatol Inflamm; 1992; 12(2):5-8. PubMed ID: 1364940
[TBL] [Abstract][Full Text] [Related]
15. [Consideration of drug absorption in customizing drug therapy].
Walter-Sack I; Haefeli WE
Ther Umsch; 2000 Sep; 57(9):557-62. PubMed ID: 11036435
[TBL] [Abstract][Full Text] [Related]
16. Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans.
Kaniwa N; Aoyagi N; Ogata H; Ejima A; Motoyama H; Yasumi H
J Pharmacobiodyn; 1988 Aug; 11(8):571-5. PubMed ID: 3236215
[TBL] [Abstract][Full Text] [Related]
17. Gastric emptying rates of drug preparations. I. Effects of size of dosage forms, food and species on gastric emptying rates.
Kaniwa N; Aoyagi N; Ogata H; Ejima A
J Pharmacobiodyn; 1988 Aug; 11(8):563-70. PubMed ID: 3236214
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
